2- ((3- ((2- (4- chlorophenyl)- 5- methyloxazol- 4- yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid

structure in first source

Also Known As:

BMS 687453; BMS-687453; BMS687453

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Chadwick, Chris: 1 article (10/2009)
2.	Janovitz, Evan B: 1 article (10/2009)
3.	Lehman-McKeeman, Lois D: 1 article (10/2009)
4.	Lowe-Krentz, Linda J: 1 article (10/2009)
5.	Vassallo, Jeffrey D: 1 article (10/2009)
6.	Wescott, Debra M: 1 article (10/2009)

1.	Muscular Diseases (Myopathy) 10/01/2009 - "Minimal myopathy induced by investigational compounds BMS-600149 and BMS-687453 increased serum fsTnI to about 30-50 ng/ml, suggesting a reasonable dynamic range for detecting mild to severe skeletal muscle toxicity. "